AKT1 and COVID-19: Targeted inhibition of Akt, which may downregulate ACE2 expression in COVID‐19 and may increase Tregs, inhibits excessive inflammation, CS, pulmonary fibrosis, and platelet activation associated with advanced COVID‐19.298